Milan: gains for Philogen
(Teleborsa) - Another bullish cue from the developer of biopharmaceutical products for the treatment of life-threatening conditions as it trades with a good +2.3% gain.In the last week Philogen underperformed the FTSE Italia Mid Cap index, therefore showing a lower performance than the benchmark.
New technical evidence points to a decline of Philogen's stock price, which could hit the most immediate support seen at the 20 Euros level. However, a sudden rebound would undermine the above scenario by triggering a bullish rise, with the most immediate resistance of 20 as a new target. In the next session we can expect a continuation of the downtrend to the key support level of 20.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 11-04-2024 09:35 AM